
Athersys ATHX
Athersys ROE Ratio | ATHX
Annual ROE Ratio Athersys
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 304.11 | -531.22 | -251.15 | -191.58 | -56.32 | -137.92 | -137.17 | -83.26 | -105.68 | -155.1 | -72.78 | -188.35 | -126.34 | -81.06 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 304.11 | -531.22 | -129.56 |
Quarterly ROE Ratio Athersys
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152.37 | 532.74 | -6738.28 | -6763.47 | -6896.11 | -7200.71 | -7749.48 | -581.43 | -519.6 | -425.35 | -320.31 | -334.18 | -306.02 | -306.3 | -321.4 | -274.32 | -257.93 | -148.92 | -68.5 | -54.65 | -84.43 | -92.86 | -129.28 | -127.18 | -134.89 | -144.57 | -155.67 | -93.91 | -11.96 | -16.39 | 13.94 | -94.18 | -143.76 | -119.45 | -112.42 | -85.5 | -103.55 | -134.79 | -187.52 | -221.01 | -187.58 | -315.61 | -347.53 | -329.39 | -371.67 | -216.93 | -159.56 | -159.34 | -22.13 | -25.1 | -53.85 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 532.74 | -7749.48 | -842.15 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
scPharmaceuticals
SCPH
|
-639.25 | - | - | $ 218 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
-151.03 | - | - | $ 105 M | ||
|
Global Blood Therapeutics
GBT
|
-154.32 | - | - | $ 4.62 B | ||
|
Inozyme Pharma
INZY
|
-176.43 | - | - | $ 207 M | ||
|
NanoString Technologies
NSTG
|
-348.24 | - | -37.43 % | $ 5.1 M | ||
|
Humanigen
HGEN
|
151.25 | - | -81.12 % | $ 4.28 M | ||
|
CNS Pharmaceuticals
CNSP
|
-350.48 | $ 3.56 | -9.07 % | $ 1.58 M | ||
|
Sorrento Therapeutics
SRNE
|
3078.97 | - | -29.58 % | $ 126 M | ||
|
Surface Oncology
SURF
|
-68.08 | - | - | $ 59.7 M | ||
|
Sierra Oncology
SRRA
|
-98.61 | - | -0.05 % | $ 1.34 B | ||
|
Vaccinex
VCNX
|
748.95 | - | -61.37 % | $ 654 K | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
66.3 | - | -19.68 % | $ 18.4 M | ||
|
Jounce Therapeutics
JNCE
|
-27.81 | - | - | $ 98.4 M | ||
|
Cocrystal Pharma
COCP
|
-139.49 | $ 0.93 | -4.11 % | $ 10.5 M | ||
|
Fortress Biotech
FBIO
|
74.19 | $ 1.89 | 6.78 % | $ 52.7 M | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Longeveron
LGVN
|
-400.07 | $ 1.65 | -9.34 % | $ 29 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Immunic
IMUX
|
1456.2 | $ 7.0 | -5.28 % | $ 1.09 B | ||
|
Immunovant
IMVT
|
-59.3 | $ 31.74 | -2.4 % | $ 5.79 B | ||
|
Mersana Therapeutics
MRSN
|
727.65 | - | - | $ 3.56 B | ||
|
Akari Therapeutics, Plc
AKTX
|
-61.07 | $ 6.83 | 1.71 % | $ 460 B | ||
|
MediWound Ltd.
MDWD
|
-126.46 | $ 13.59 | 0.33 % | $ 370 M | ||
|
CymaBay Therapeutics
CBAY
|
-36.05 | - | - | $ 3.45 B | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-169.75 | - | - | $ 384 M | ||
|
Keros Therapeutics
KROS
|
28.7 | $ 11.04 | -3.07 % | $ 411 M | ||
|
Kazia Therapeutics Limited
KZIA
|
-169.83 | $ 4.9 | -8.75 % | $ 75.9 M | ||
|
Allakos
ALLK
|
-146.95 | - | - | $ 28.6 M | ||
|
Timber Pharmaceuticals
TMBR
|
-370.23 | - | - | $ 717 K | ||
|
G1 Therapeutics
GTHX
|
-135.55 | - | - | $ 370 M | ||
|
Amryt Pharma plc
AMYT
|
0.28 | - | - | $ 621 M | ||
|
BioVie
BIVI
|
-214.92 | $ 0.79 | -13.64 % | $ 5.72 M | ||
|
Kinnate Biopharma
KNTE
|
-70.7 | - | - | $ 123 M | ||
|
Mustang Bio
MBIO
|
-20.16 | $ 0.35 | -4.3 % | $ 1.72 M | ||
|
Cerevel Therapeutics Holdings
CERE
|
-64.24 | - | - | $ 7.29 B | ||
|
NexImmune
NEXI
|
-921.57 | - | 70.13 % | $ 4.12 M | ||
|
Theravance Biopharma
TBPH
|
35.69 | $ 17.03 | 0.03 % | $ 857 M | ||
|
Nuvation Bio
NUVB
|
-66.93 | $ 3.79 | -0.52 % | $ 1.29 B | ||
|
IMV
IMV
|
575.45 | - | - | $ 13.1 M | ||
|
Chimerix
CMRX
|
-72.64 | - | - | $ 756 M | ||
|
LogicBio Therapeutics
LOGC
|
-130.27 | - | - | $ 229 M | ||
|
AbbVie
ABBV
|
-55.54 | $ 286.15 | 0.94 % | $ 506 B | ||
|
89bio
ETNB
|
-91.59 | - | - | $ 1.55 B | ||
|
Harpoon Therapeutics
HARP
|
-1254.51 | - | - | $ 763 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 143.74 | -2.76 % | $ 18.8 B | ||
|
Amgen
AMGN
|
89.06 | $ 435.4 | -0.21 % | $ 234 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
176.55 | $ 0.29 | -11.35 % | $ 3.57 B | ||
|
Seagen
SGEN
|
-21.77 | - | - | $ 42.2 B | ||
|
Baudax Bio
BXRX
|
242.53 | - | 0.59 % | $ 63 K |